MEDEA S.r.l. is the ThrombUS+ partner leading exploitation strategy, IP management, and impact assurance to bring AI-powered DVT monitoring technology to market.
Daily Archives: July 20, 2026
1 post
MEDEA S.r.l. is the ThrombUS+ partner leading exploitation strategy, IP management, and impact assurance to bring AI-powered DVT monitoring technology to market.